Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - A review

Placenta

Volumn 21, Issue SUPPL.1, 2000, Pages

  Ahmed, A ^a   Dunk, C ^a   Ahmad, S ^a   Khaliq, A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; MESSENGER RNA; ONCOPROTEIN; OXYGEN; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL; FEMALE; FETUS HYPOXIA; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; REVIEW; VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FETAL HYPOXIA; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0012270024     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0524     Document Type: Article

References (97)

1. Ahmed A (1997) Angiogenic growth factors in pregnancy. In Trophoblast Research, Early Pregnancy, Vol 9 (Eds) Aplin JD, Kaufmann P, Schaaps JP & Foidart JM, pp. 215-258. New York: University of Rochester Press.
2. Ahmed A & Kilby MD (1997) Placental insufficiency: hypoxia or hyperoxia? Lancet, 350, 826-827.
3. Ahmed AS, Whittle MJ & Khaliq A (1997) Differential expression of placenta growth factor (P1GF) and vascular endothelial growth factor (VEGF) in abnormal placentation. J Soc Gynaecol Invest, 4, A663.
4. Ahmed AS, Li XF, Dunk CE, Whittle MJ & Rollason T (1995) Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors, 12, 235-243.
5. Ahmed AS, Dunk CE, Kniss D & Wilkes M (1997) Role of VEGF receptor (Flt-1) in mediating calcium dependant nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest, 76, 779-791.
6. Alvarez H, Morel RL, Benedetti WL & Scavarelli M (1969) Trophoblast hyperplasia and maternal arterial pressure at term. Am J Obstet Gynaecol, 105, 1015-1021.
7. Alvarez H, Benedetti WL, Morel RL & Scavarelli M (1970) Trophoblast development gradient and its relationship to placental hemodynamics. Am J Gynaecol, 106, 416-420.
8. Anthony FW, Evans PW, Wheeler T & Wood PJ (1997) Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem, 34, 276-280.
9. Arnholdt H, Meisel F, Fandrey K & Lohrs U (1991) Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol, 60, 365-372.
10. Arts NFT (1961) Investigations on the vascular system of the placenta. 1. General introduction and the fetal vascular system. Am J Obstet Gynaecol, 82, 147-158.
11. Athanassiades A & Lala PK (1998) Role of placenta growth factor (P1GF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta, 19, 465-473.
12. Benirschke K & Kaufmann P (Eds) (1995) Pathology of Human Placenta. London: Springer-Verlag.
13. Benjamin LE & Keshet E (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA, 94, 8761-8766.
14. Birkenhager R, Schneppe B, Rockl W, Wilting J, Weich HA & McCarthy JEG (1996) Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem J, 3126, 703-707.
15. Brock TA, Dvorak HF & Senger DR (1991) Tumor secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor in human endothelial cells. Am J Pathol, 138, 213-221.
16. Brosens I, Dixon HG & Robertson WB. (1997). Fetal growth retardation and the arteries of the placental bed. Br J Obstet and Gynaecol, 84, 656-664.
17. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR & Dvorak HF (1993a) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 59, 4727-4735.
18. Brown LF, Berse B, Jackman RW, Toganazi K, Manseau EJ, Dvorak HF & Senger DR (1993b) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol, 143, 1255-1262.
19. Carmieliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380 (6573), 435-439.
20. Castellucci M, Scheper M, Scheffen I, Celona A & Kaufmann P (1990) The development of the human placental villous tree. Anat Embryol, Berlin, 181, 117-128.
21. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N & Smith SK (1994) Localization and activation of the receptor for vascular endothelial growth factor on human trophoblast and choriocarcinoma cells. Biol Reprod, 51, 524-530.
22. Clark DE, Smith SK, Sharkey AM & Charnock Jones DS (1996) Localization of VEGF and expression of its receptors flt-1 and KDR in human placenta throughout pregnancy. Hum Reprod, 11, 1080-1098.
23. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R & Charnock-Jones DS (1998) A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod, 59, 1540-1548.
24. Clauss M, Weich H, Brier G, Knies U, Rockl W, Waltenberger J & Risau W (1996) The vascular endothelial growth factor receptor flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem, 271, 17 629-17 634.
25. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R & Feder J (1989) Human vascular permeability factor: isolation from U937 cells. J Biol Chem, 264, 20 017-20 024.
26. Crescimanno C, Marzioni D, Persico MG, Vuckovic M, Muhauser J & Castelucci M (1995) Expression of bFGF, P1GF and their receptors in the human placenta. Placenta, 16, A13.
27. Davidoff M & Scheibler TH (1970) Über den feinbau der meerscwheinchenplacenta wahrend der entwicklung. Anat Embryol, Berlin, 130, 234-254.
28. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N & Williams LT (1992) The fms like tyrosine kinase a receptor for vascular endothelial growth factor. Science, 255, 989-991.
29. Demir R, Kaufmann P, Castelucci M, Erbengi T & Kotowski A (1989) Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat, Basel, 136, 190-203.
30. Demir R, Kosanke G, Kohen G, Kertschanka S & Kaufmann P (1997) Classification of human placental stem villi: review of stuctural and functional aspects. Microsc Res Technique, 38, 29-41.
31. Dunk C & Ahmed A (1997) Oxygen modulates vascular endothelial cell growth factor (VEGF) secretion, trophoblast proliferation & VEGF receptor activation. Placenta, 18, A20.
32. Dvorak HF, Brown LF, Detmar M & Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability & angiogenesis. Am J Pathol, 146, 1029-1039.
33. Eik-Nes SH, Brubakk AO & Ulstein M (1980) Measurement of human fetal blood flow. Br Med J, 1, 283-284.
34. Ferrara N & Henzel WJ (1989) Pituitary endothelial cells secrete a novel heparin binding growth factor for vascular endothelial cells. Biochem Biophys Res Commun, 161, 851-858.
35. Ferriani RA, Ahmed A, Sharkey AM & Smith SK (1994) Colocalization of acidic and basic fibroblast growth factor (FGF) inhuman placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors, 10, 259.
36. Fong GH, Rossant J, Gersenstein M & Breitman ML (1995) Role of the Fit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70.
37. Fox H (1964) The villous cytotrophoblast as an index of placental ischaemia. J Obstet Gynaecol Br Commonw, 71, 885-893.
38. Fox H (1970) Effect hypoxia on trophoblast in organ culture: a morphologic and autoradiographic study. Am J Obstet Gynaecol, 107, 1058-1064.
39. Frusca T, Morassi L, Pecorelli S, Grigolato P and Gastaldi A. (1989). Histological features of uteroplacental vessels in normal and hypertensive pregnancies in relation to birthweight. Br J Obstet Gynaecol, 96, 835-839.
40. Garg UC & Hassid A (1989) Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest, 83, 1774-1777.
41. Genbacev O, Joslin R, Damsky CH, Polliotti BM & Fisher SJ (1996) Hypoxia alters early gestation human cytotrophoblast differentiation/ invasion in vitro and models placental defects that occur in preeclampsia. J Clin Invest, 97, 540-550.
42. Gleadle JM, Ebert BL, Firth JD & Ratcliffe PJ (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals & chelating agents. Am J Physiol, 268, C1362-C1368.
43. Gooch KJ, Dangler CA & Frangos JA (1997) Exogenous, basal & flow induced nitric oxide production and endothelial cell proliferation. J Cell Physiol, 171, 252-258.
44. Hauser S & Weich HA (1993). A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors, 9, 259-268.
45. Hendricks S, Sarensen TK & Wong KY (1989) Doppler umbilical artery waveforms indices-normal values from fourteen to forty two weeks. Am J Obstet Gynecol, 161, 761-765.
46. Hitschold T, Mutefering H, Ulrich S & Berle P (1996) Does extremely low fetoplacenal impedance as estimated by umbilical artery Doppler velocimetry also indicate fetuses at risk? Ultrasound Gynecology, 8, 39A.
47. Jackson MR, Carney EW, Lye SJ & Ritchie JW (1994) Localisation of two angiogenic growth factors (PDECGF and VEGF) in human placenta throughout gestation. Placenta, 15, 341-353.
48. Karsdorp VH, Dirks BK, van der Linden JC, van Vugt JM, Baak JP & van Geijn HP (1996) Placenta morphology and absent or reversed end diastolic flow velocities in the umbilical artery: a clinical and morphometrical study. Placenta, 17, 393-399.
49. Kaufmann P, Bruns U, Leiser R, Luckhardt M & Winterhager E (1985) The fetal vascularisation of term human placental villi. 11. Intermediate and terminal villi. Anat Embryol, Berlin, 173, 203-214.
50. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J & Connolly DT (1989) Vascular permeability factor, an endothelial mitogen related to PDGF. Science, 246, 1309-1312.
51. Kendall RL & Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA, 15, 10705-10709.
52. Kendall RL, Wang G & Thomas KA (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1 & its heterodimerization with KDR. Biochem Biophys Res Commun, 13, 226, 324-328.
53. Khaliq A, Shams M, Li XF, Sisi P, Acevedo CA, Weich HA, Whittle MJ & Ahmed A (1996) Localization of placenta growth factor (P1GF) in human term placenta. Growth Factors, 13, 243-250.
54. Khaliq A, Foreman D, Ahmed A, Weich H, McLeod D & Boulton M (1999) Increased expression of placenta growth factor (P1GF) in proliferative diabetic retinopathy. Lab Invest, 78, 109-116.
55. Kilby MD, Afford S, Li XF, Strain AJ, Ahmed A & Whittle MJ (1996) Localization of hepatocyte growth factor (HGF) and its receptor (c-met) protein and mRNA in human term placenta. Growth Factors, 13, 133-139.
56. King BF (1987) Ultrastructural differentiation of stromal and vascular components in early macaque placental villi. Am J Anat, 178, 30-44.
57. Kingdom JCP & Kaufmann P (1997) Oxygen and placental villous development: Origins of fetal hypoxia. Placenta, 18, 613-621.
58. Kiserud T, Hellevik LR, Eik-Nes SH, Angelsen BA & Blaas HG (1994) Estimate of the pressure gradient across the fetal ductus venosus based on Doppler velocimetry. Ultrasound Med Biol, 20, 225-232.
59. Kohen G (1999) Anatomy of the Stemvillus. IUGR (Eds) Baker P & Kingdom JCP. London: Springer-Verlag.
60. Kohen G & Kingdom JCP (2000) Villous development and the pathogenesis of IUGR. London: Springer-Verlag. Pp 131-145.
61. Krebs C, Longo LD & Leiser D (1997) Term ovine placental vasculature: comparison of sea level and high altitude conditions by corrosion cast and histomorphometry. Placenta, 18, 43-51.
62. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA & Kingdom JCP (1996) Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol, 175, 534-1542.
63. Kurz H, Wilting J, Sandau K & Christ B (1998) Automated evaluation of angiogenic effects mediated by VEGF and P1GF homo- and heterodimers. Microvasc Res, 55, 92-102.
64. Leiser R, Luckhardt M, Kaufmann P, Winterhager E & Bruns U (1985) The fetal vascularization of term human placental villi. I. Peripheral stem villi. Anat Embryol, Berlin, 173, 71-80.
65. Macara LM, Kingdom JCP, Kaufmann P, Kohnen G, Hair J, More IRA, Lyall F & Greer IA (1996) Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta, 17, 37-48.
66. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P & Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA, 88, 9267-9271.
67. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P & Pepper MS (1995) Vascular endothelial growth factor increases urokinase receptor expression of vascular endothelial cells. J Biol Chem, 270, 9709-9716.
68. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W & Ullrich A (1993) High affinity vascular endothelial growth factor binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
69. Park JE, Chen HH, Winer J, Houck HA & Ferrara N (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo & high affinity binding to flt-1 but not flk-1/KDR. J Biol Chem, 269, 25 646-25 654.
70. Plate KH, Brier G, Weich HA & Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848.
71. Plouet J, Schilling J & Gospodarowicz D (1989) Isolation and characterisation of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J, 8, 3801-3806.
72. Reilly FD & Russell PT (1977) Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec, 188, 277-286.
73. Rodesch F, Simon P, Donner C & Jauniaux E (1992) Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol, 80, 283-285.
74. Rousseau S, Huole F, Landry J & Huot J (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene, 15, 2169-2177.
75. Schweiki D, Itin A, Neufeld G, Gitay-Goren H & Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature, 359, 843-845.
76. Senger DR, Peruzzi CA, Feder J & Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promoted accumulation of ascites fluid. Science, 219, 983-985.
77. Seymour LW, Shoaibi MA, Martin A, Ahmed A, Elvin P, Kerr D & Wakelam M (1996) Vascular endothelial growth factor stimulates protein kinase C dependant phospholipase D activity in endothelial cells. Lab Invest, 75, 427-437.
78. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML & Schuh AC (1995) Failure of blood island formation and vasculogenesis in flk-1 deficient mice. Nature, 376, 62-66.
79. Shams M & Ahmed A (1994) Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors, 11, 105-111.
80. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD & Smith SK (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil, 99, 609-615.
81. Shiraishi S, Nakagawa K, Kinukawa N, Nakano H & Sueishi K (1996) Immunohistochemical localisation of vascular endothelial growth factor in the human placenta. Placenta, 17, 111-121.
82. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR & Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta, 18, 657-665.
83. Senger DR, Peruzzi CA, Feder J & Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promoted accumulation of ascites fluid. Science, 219, 983-985.
84. Stavri G, Zachary I, Baskerville P, Martin J & Erusalimsky J (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation, 92, 5-8.
85. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Sagimura T and Terada M (1994). Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54, 4233-4237.
86. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitriov D, Gospodarowicz DC & Bohlen P (1992) Identification of KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun, 187, 1579-1586.
87. Tsurumi Y, Murohara T, Kransinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T & Isner JM (1997) Reciprocal regulation between VEGF and NO in the regulation of endothelial integrity. Nature Med, 3, 879-886.
88. Tuder RM, Flook BE & Voelkel NF (1995) Increased gene expression for VEGF and the VEGF receptors KDR/Flk-1 and Flt-1 in lungs exposed to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest, 95, 1798-1807.
89. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T & Kitamura N (1995) Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature, 373, 702-705.
90. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C & Isner JM (1997) Vascular endothelial growth factor (VEGF)/Vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation, 95, 1030-1037.
91. Vuckovic M, Ponting J, Terman BI, Niketic V, Seif MW & Kumar S (1996) Expression of the vascular endothelial growth factor receptor, KDR, in human placenta. J Anat, 188, 361-366.
92. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K & Halmesmaki E (1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod, 56, 489-494.
93. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M & Heldin CH (1994) Different signal transduction properties of KDR and Fit-1, two receptors for vascular endothelial growth factor. J Biol Chem, 269, 26 988-26 995.
94. Watanabe Y & Dvorak HF (1997) Vascular permeability factor/vascular endothelial growth factor inhibits anchorage dependant apopotosis in microvessel endothelial cells by inducing scaffold formation. Exp Cell Res, 233, 340-349.
95. Wheeler T, Elcock CL & Anthony FW (1995) Angiogenesis in the placental environment. Placenta, 16, 289-296.
96. Wilting J, Birkenhager R, Eichmann A, Kurz H, Martiny-Baron G, Marme D, McCarthy JE, Christ B & Weich HA (1996) VEGF(121) induces proliferation of vascular endothelial cells and expression of Flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Devel Biol, 176, 76-85.
97. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G & Shibuya M (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt-1 tyrosine kinase receptor family (Flt-1 and KDR). Oncogene, 9, 2683-2690.